Clearstead Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Clearstead Advisors's OGN Position: Q2 2026 in Review
Clearstead Advisors increased its Organon & Co (OGN) stake by 1.8% in Q2 2026, buying an estimated $108 and bringing the position to 506 shares worth $6.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.
Clearstead Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $218K in Q2 2021. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Clearstead Advisors held 506 shares of Organon & Co worth $6.85K as of Q2 2026.
- Clearstead Advisors bought 9 Organon & Co shares in Q2 2026, an estimated $108.
- Organon & Co made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2106 holding.
- Clearstead Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- Clearstead Advisors's Organon & Co position peaked at $218K in Q2 2021.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.